Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1970 2
1971 2
1972 1
1973 2
1974 2
1975 2
1976 1
1977 2
1978 1
1979 3
1980 2
1982 1
1983 2
1984 1
1985 1
1986 2
1988 2
1989 2
1990 5
1991 2
1992 4
1994 1
1995 1
1996 3
1997 2
1998 1
1999 4
2000 5
2001 3
2002 7
2003 5
2004 4
2005 9
2006 21
2007 18
2008 10
2009 25
2010 16
2011 21
2012 28
2013 23
2014 21
2015 25
2016 21
2017 13
2018 12
2019 18
2020 14
2021 22
2022 10
2023 6
2024 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

387 results

Results by year

Filters applied: . Clear all
Page 1
Parabens and their effects on the endocrine system.
Nowak K, Ratajczak-Wrona W, Górska M, Jabłońska E. Nowak K, et al. Among authors: gorska m. Mol Cell Endocrinol. 2018 Oct 15;474:238-251. doi: 10.1016/j.mce.2018.03.014. Epub 2018 Mar 27. Mol Cell Endocrinol. 2018. PMID: 29596967 Review.
Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy: A Randomized Clinical Trial.
Bakris GL, Agarwal R, Chan JC, Cooper ME, Gansevoort RT, Haller H, Remuzzi G, Rossing P, Schmieder RE, Nowack C, Kolkhof P, Joseph A, Pieper A, Kimmeskamp-Kirschbaum N, Ruilope LM; Mineralocorticoid Receptor Antagonist Tolerability Study–Diabetic Nephropathy (ARTS-DN) Study Group. Bakris GL, et al. JAMA. 2015 Sep 1;314(9):884-94. doi: 10.1001/jama.2015.10081. JAMA. 2015. PMID: 26325557 Clinical Trial.
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes.
Green JB, Bethel MA, Armstrong PW, Buse JB, Engel SS, Garg J, Josse R, Kaufman KD, Koglin J, Korn S, Lachin JM, McGuire DK, Pencina MJ, Standl E, Stein PP, Suryawanshi S, Van de Werf F, Peterson ED, Holman RR; TECOS Study Group. Green JB, et al. N Engl J Med. 2015 Jul 16;373(3):232-42. doi: 10.1056/NEJMoa1501352. Epub 2015 Jun 8. N Engl J Med. 2015. PMID: 26052984 Free article. Clinical Trial.
Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial.
Sherry N, Hagopian W, Ludvigsson J, Jain SM, Wahlen J, Ferry RJ Jr, Bode B, Aronoff S, Holland C, Carlin D, King KL, Wilder RL, Pillemer S, Bonvini E, Johnson S, Stein KE, Koenig S, Herold KC, Daifotis AG; Protégé Trial Investigators. Sherry N, et al. Lancet. 2011 Aug 6;378(9790):487-97. doi: 10.1016/S0140-6736(11)60931-8. Epub 2011 Jun 28. Lancet. 2011. PMID: 21719095 Free PMC article. Clinical Trial.
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome.
Pfeffer MA, Claggett B, Diaz R, Dickstein K, Gerstein HC, Køber LV, Lawson FC, Ping L, Wei X, Lewis EF, Maggioni AP, McMurray JJ, Probstfield JL, Riddle MC, Solomon SD, Tardif JC; ELIXA Investigators. Pfeffer MA, et al. N Engl J Med. 2015 Dec 3;373(23):2247-57. doi: 10.1056/NEJMoa1509225. N Engl J Med. 2015. PMID: 26630143 Free article. Clinical Trial.
Update on type 2 immunity.
Gorska MM. Gorska MM. J Allergy Clin Immunol. 2024 Nov 9:S0091-6749(24)01180-1. doi: 10.1016/j.jaci.2024.11.003. Online ahead of print. J Allergy Clin Immunol. 2024. PMID: 39528097 Review.
Natural killer cells in asthma.
Gorska MM. Gorska MM. Curr Opin Allergy Clin Immunol. 2017 Feb;17(1):50-54. doi: 10.1097/ACI.0000000000000327. Curr Opin Allergy Clin Immunol. 2017. PMID: 27841766 Free PMC article. Review.
Protein tyrosine phosphatases in pathological process.
Kuban-Jankowska A, Gorska M, Knap N, Cappello F, Wozniak M. Kuban-Jankowska A, et al. Among authors: gorska m. Front Biosci (Landmark Ed). 2015 Jan 1;20(2):377-88. doi: 10.2741/4314. Front Biosci (Landmark Ed). 2015. PMID: 25553456 Free article. Review.
Designer drugs – still a threat?
Rozenek EB, Wilczyńska K, Górska M, Waszkiewicz N. Rozenek EB, et al. Among authors: gorska m. Przegl Epidemiol. 2019;73(3):337-347. doi: 10.32394/pe.73.23. Przegl Epidemiol. 2019. PMID: 31766831 Review.
Ticagrelor in Patients with Stable Coronary Disease and Diabetes.
Steg PG, Bhatt DL, Simon T, Fox K, Mehta SR, Harrington RA, Held C, Andersson M, Himmelmann A, Ridderstråle W, Leonsson-Zachrisson M, Liu Y, Opolski G, Zateyshchikov D, Ge J, Nicolau JC, Corbalán R, Cornel JH, Widimský P, Leiter LA; THEMIS Steering Committee and Investigators. Steg PG, et al. N Engl J Med. 2019 Oct 3;381(14):1309-1320. doi: 10.1056/NEJMoa1908077. Epub 2019 Sep 1. N Engl J Med. 2019. PMID: 31475798 Free article. Clinical Trial.
387 results